Schizophrenia Research
Volume 73, Issue 2 , Pages 209-219 , 1 March 2005

N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration

  • Vicente Molina

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +34-923-291102; fax: +34-923-291383.
    • Department of Psychiatry, Hospital Clı́nico, Paseo de S. Vicente 58-182, Salamanca 37007, Spain
    • ,
  • Javier Sánchez

      Affiliations

    • Department of Experimental Medicine, Hospital “Gregorio Marañón”, Madrid, Spain
    • ,
  • Santiago Reig

      Affiliations

    • Department of Experimental Medicine, Hospital “Gregorio Marañón”, Madrid, Spain
    • ,
  • Javier Sanz

      Affiliations

    • Department of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Carlos Benito

      Affiliations

    • Department of Radiology, Hospital “Gregorio Marañón”, Madrid, Spain
    • ,
  • Cristina Santamarta

      Affiliations

    • Department of Experimental Medicine, Hospital “Gregorio Marañón”, Madrid, Spain
    • ,
  • Javier Pascau

      Affiliations

    • Department of Experimental Medicine, Hospital “Gregorio Marañón”, Madrid, Spain
    • ,
  • Fernando Sarramea

      Affiliations

    • Department of Psychiatry, Hospital Reina Sofı́a, Córdoba, Spain
    • ,
  • Juan D. Gispert

      Affiliations

    • Department of Experimental Medicine, Hospital “Gregorio Marañón”, Madrid, Spain
    • ,
  • José M. Misiego

      Affiliations

    • Department of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Tomás Palomo

      Affiliations

    • Department of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Manuel Desco

      Affiliations

    • Department of Experimental Medicine, Hospital “Gregorio Marañón”, Madrid, Spain

Received 3 February 2004 ,Revised 3 February 2004 ,Accepted 4 February 2004.

References 

  1. Angelie E, Bonmartin A, Boudraa A, Gonnaud PM, Mallet JJ, Sappey-Marinier D. Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study. Am. J. Neuroradiol. 2001;22:119–127
  2. Bartha R, al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, et al. A short echo proton magnetic resonance spectroscopy study of the left mesial–temporal lobe in first-onset schizophrenic patients. Biol. Psychiatry. 1999;45:1403–1411
  3. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 1996;153:1554–1563
  4. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry. 1998;43:641–648
  5. Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, et al. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 1998;155:1376–1383
  6. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol. Psychiatry. 2001;49:39–46
  7. Bertolino A, Sciota D, Brudaglio F, Altamura M, Blasi G, Bellomo A, et al. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am. J. Psychiatry. 2003;160:483–489
  8. Block W, Bayer TA, Tepest R, Traber F, Rietschel M, Muller DJ, et al. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci. Lett. 2000;289:147–151
  9. Boogaart A, Ormondt D, Pijnapel WWF, Beer RD, Ala-Korpela M. Removal of the water resonance from 1H magnetic resonance spectra. In:  McWhiter JG editors. Mathematics in Processing III. Oxford: Clarendon Press; 1994;p. 175–195
  10. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann. N.Y. Acad. Sci. 1987;508:333–348
  11. Brooks JC, Roberts N, Kemp GJ, Gosney MA, Lye M, Whitehouse GH. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb. Cortex. 2001;11:598–605
  12. Buckley PF, Moore C, Long H, Larkin C, Thompson P, Mulvany F, et al. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiatry. 1994;36:792–800
  13. Bustillo JR, Lauriello J, Rowland LM, Jung RE, Petropoulos H, Hart BL, et al. Effects of Chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia. Psychiatry Res. 2001;107:135–149
  14. Callicott JH, Bertolino A, Egan MF, Mattay VS, Langheim FJ, Weinberger DR. Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophrenia. Am. J. Psychiatry. 2000;157:1646–1651
  15. Cecil KM, Lenkinski RE, Gur RE, Gur RC. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology. 1999;20:131–140
  16. Deicken RF, Zhou L, Corwin F, Vinogradov S, Weiner MW. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am. J. Psychiatry. 1997;154:688–690
  17. Deicken RF, Zhou L, Schuff N, Weiner MW. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr. Res. 1997;27:65–71
  18. Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol. Psychiatry. 1998;43:483–488
  19. Deicken RF, Johnson C, Eliaz Y, Schuff N. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia. Am. J. Psychiatry. 2000;157:644–647
  20. Delamillieure P, Fernandez J, Constans JM, Brazo P, Benali K, Abadie P, et al. Proton magnetic resonance spectroscopy of the medical prefrontal cortex in patients with deficit schizophrenia: preliminary report. Am J Psychiatry. 2000;157:641–643
  21. Delamillieure P, Constans JM, Fernandez J, Brazo P, Benali K, Courtheoux P, et al. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr. Bull. 2002;28:329–339
  22. DeLisi LE. Defining the course of brain structural change and plasticity in schizophrenia. Psychiatry Res. 1999;92:1–9
  23. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr. Res. 2000;41:389–395
  24. Ende G, Braus DF, Walter S, Henn FA. Lower concentration of thalamic N-acetylaspartate in patients with schizophrenia: a replication study. Am. J. Psychiatry. 2001;158:1314–1316
  25. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2003;253:9–15
  26. Fannon D, Simmons A, Tennakoon L, O'Ceallaigh S, Sumich A, Doku V, et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol. Psychiatry. 2003;54:587–598
  27. Fukuzako H, Fukuzako T, Hashiguchi T, Kodama S, Takigawa M, Fujimoto T. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. Am. J. Psychiatry. 1999;156:1205–1208
  28. Grachev ID, Swarnkar A, Szeverenyi NM, Ramachandran TS, Apkarian AV. Aging alters the multichemical networking profile of the human brain: an in vivo (1)H-MRS study of young versus middle-aged subjects. J. Neurochem. 2001;77:292–303
  29. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry. 1998;55:145–152
  30. Harada M, Miyoshi H, Otsuka H, Nishitani H, Uno M. Multivariate analysis of regional metabolic differences in normal ageing on localised quantitative proton MR spectroscopy. Neuroradiology. 2001;43:448–452
  31. Hoff AL, Sakuma M, Wieneke M, Horon R, Kushner M, DeLisi LE. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. Am. J. Psychiatry. 1999;156:1336–1341
  32. Hollingshead A, Frederick R. Social stratification and psychiatric disorders. Am. Sociol. Rev. 1953;18:163–189
  33. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II. Biol. Psychiatry. 2000;48:369–380
  34. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry. 1999;46:729–739
  35. Lim KO, Adalsteinsson E, Spielman D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch. Gen. Psychiatry. 1998;55:346–352
  36. Lindquist DM, Hawk RM, Karson CN, Komoroski RA. Effects of antipsychotic drugs on metabolite ratios in rat brain in vivo. Magn. Reson. Med. 2000;43:355–358
  37. Lundbom N, Barnett A, Bonavita S, Patronas N, Rajapakse J, Tedeschi G, et al. MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain. Magn. Reson. Med. 1999;41:841–845
  38. Maier M, Ron MA, Barker GJ, Tofts PS. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol. Med. 1995;25:1201–1209
  39. McGlashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr. Bull. 1988;14:515–542
  40. Molina V, Reig S, Sanz J, Benito C, Pascau J, Collazos F, et al. Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia. Schizophr. Res. 2002;58:305–312
  41. Nasrallah HA, Skinner TE, Schmalbrock P, Robitaille PM. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. Br. J. Psychiatry. 1994;165:481–485
  42. Nikkilä HV, Müller K, Ahokas A, Miettinen K, Rimón R, Andersson LC. Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes. Am. J. Psychiatry. 1999;156:1725–1729
  43. Omori M, Murata T, Kimura H, Koshimoto Y, Kado H, Ishimori Y, et al. Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy. Psychiatry Res. 2000;98:155–162
  44. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281–288
  45. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T, et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry. 1999;56:649–654
  46. Saunders DE, Howe FA, van den Boogaart A, Griffiths JR, Brown MM. Aging of the adult human brain: in vivo quantitation of metabolite content with proton magnetic resonance spectroscopy. J. Magn. Reson. Imaging. 1999;9:711–716
  47. Stanley JA, Williamson PC, Drost DJ, Carr TJ, Rylett RJ, Malla A, et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 1995;52:399–406
  48. Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr. Bull. 1996;22:597–609
  49. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 1993;13:981–989
  50. Vanhamme L, Van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J. Magn. Reson. 1997;129:35–43
  51. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 1998;155:1661–1670
  52. Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N, et al. 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. NeuroReport. 2002;13:2133–2137

PII: S0920-9964(04)00049-0

doi: 10.1016/j.schres.2004.02.001

Schizophrenia Research
Volume 73, Issue 2 , Pages 209-219 , 1 March 2005

Article Tools

* Image Usage & Resolution